Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma
- 1 January 2016
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 9 (1) , 96-104
Abstract
Bronchial dysplasia (BD), a presumed precursor of pulmonary squamous cell carcinoma (SCC), rarely progresses to invasive cancer. A high-risk cohort at the University of Colorado provided an opportunity to directly sample airway epithelium at mapped sites on successive bronchoscopies. We have hypothesized that persistent dysplastic lesions showing a similar or higher level of dysplasia on follow-up biopsy, are associated with increased risk for the development of SCC. Endoscopic biopsies from 188 high-risk subjects were histologically classified according to the current WHO classification for BD using a numeric histology score ranging from 1 to 8 representing normal bronchial mucosa through invasive lung cancer. Differences in follow-up histology scores were compared between sites classified by clinical, histologic, and immunohistochemical variables. Subjects with a higher frequency of sites that persist or progress to high-grade dysplasia (≥37.5% persist/progress, N = 35 versus N = 114) show a significant association with development of incident invasive SCC (adjusted HR, 7.84; 95% confidence interval, 1.56–39.39), and those with incident lung SCC have adjusted mean follow-up histology scores 1.55 U higher than in subjects without lung cancer. Current smoking, elevated Ki67 growth fraction, histologic features of angiogenic squamous dysplasia (ASD) and higher histology score in baseline biopsies are significantly associated with increased follow-up histology scores. These results show that persistent BD is associated with the development of invasive SCC. Furthermore, increased expression of Ki67, the presence of angiogenic change and degree of baseline atypia are associated with persistence of BD. Cancer Prev Res; 9(1); 96–104. ©2015 AACR.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- Oral Iloprost Improves Endobronchial Dysplasia in Former SmokersCancer Prevention Research, 2011
- Vascular Endothelial Growth Factor Receptor 2–Targeted Chemoprevention of Murine Lung TumorsCancer Prevention Research, 2010
- Progressive 3q Amplification Consistently Targets SOX2 in Preinvasive Squamous Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Telomere Maintenance and DNA Damage Responses during Lung CarcinogenesisClinical Cancer Research, 2010
- Natural history of bronchial preinvasive lesionsCancer and Metastasis Reviews, 2010
- Recurrent Genomic Gains in Preinvasive Lesions as a Biomarker of Risk for Lung CancerPLOS ONE, 2009
- A Randomized Phase II Chemoprevention Trial of 13-CIS Retinoic Acid with Or without α Tocopherol or Observation in Subjects at High Risk for Lung CancerCancer Prevention Research, 2009
- Chromosomal Aneusomy in Bronchial High-Grade Lesions Is Associated with Invasive Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Analysis of c-ErbB1/Epidermal Growth Factor Receptor and c-ErbB2/HER-2 Expression in Bronchial Dysplasia: Evaluation of Potential Targets for Chemoprevention of Lung CancerClinical Cancer Research, 2006
- Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysisLung Cancer, 2005